FTC Staff Issues FY 2013 Report on Branded Drug Firms’ Patent Settlements with Generic Competitors
Date
In Fiscal Year 2013, companies filed a total of 145 final patent dispute settlements, of which 29 created potential “pay-for-delay” agreements between branded and generic drug companies, according to...